Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Live-Attenuated
1.2.3 Inactivated
1.2.4 Recombinant Sub Unit and Toxoid
1.3 Market by Application
1.3.1 Global Disease Control and Prevention Vaccine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pediatric Vaccine
1.3.3 Adult Vaccine
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Disease Control and Prevention Vaccine Market Perspective (2018-2029)
2.2 Disease Control and Prevention Vaccine Growth Trends by Region
2.2.1 Global Disease Control and Prevention Vaccine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Disease Control and Prevention Vaccine Historic Market Size by Region (2018-2024)
2.2.3 Disease Control and Prevention Vaccine Forecasted Market Size by Region (2024-2029)
2.3 Disease Control and Prevention Vaccine Market Dynamics
2.3.1 Disease Control and Prevention Vaccine Industry Trends
2.3.2 Disease Control and Prevention Vaccine Market Drivers
2.3.3 Disease Control and Prevention Vaccine Market Challenges
2.3.4 Disease Control and Prevention Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Disease Control and Prevention Vaccine Players by Revenue
3.1.1 Global Top Disease Control and Prevention Vaccine Players by Revenue (2018-2024)
3.1.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Players (2018-2024)
3.2 Global Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Disease Control and Prevention Vaccine Revenue
3.4 Global Disease Control and Prevention Vaccine Market Concentration Ratio
3.4.1 Global Disease Control and Prevention Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Disease Control and Prevention Vaccine Revenue in 2022
3.5 Disease Control and Prevention Vaccine Key Players Head office and Area Served
3.6 Key Players Disease Control and Prevention Vaccine Product Solution and Service
3.7 Date of Enter into Disease Control and Prevention Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Disease Control and Prevention Vaccine Breakdown Data by Type
4.1 Global Disease Control and Prevention Vaccine Historic Market Size by Type (2018-2024)
4.2 Global Disease Control and Prevention Vaccine Forecasted Market Size by Type (2024-2029)
5 Disease Control and Prevention Vaccine Breakdown Data by Application
5.1 Global Disease Control and Prevention Vaccine Historic Market Size by Application (2018-2024)
5.2 Global Disease Control and Prevention Vaccine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Disease Control and Prevention Vaccine Market Size (2018-2029)
6.2 North America Disease Control and Prevention Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Disease Control and Prevention Vaccine Market Size by Country (2018-2024)
6.4 North America Disease Control and Prevention Vaccine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Disease Control and Prevention Vaccine Market Size (2018-2029)
7.2 Europe Disease Control and Prevention Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Disease Control and Prevention Vaccine Market Size by Country (2018-2024)
7.4 Europe Disease Control and Prevention Vaccine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Disease Control and Prevention Vaccine Market Size (2018-2029)
8.2 Asia-Pacific Disease Control and Prevention Vaccine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Disease Control and Prevention Vaccine Market Size by Region (2018-2024)
8.4 Asia-Pacific Disease Control and Prevention Vaccine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Disease Control and Prevention Vaccine Market Size (2018-2029)
9.2 Latin America Disease Control and Prevention Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Disease Control and Prevention Vaccine Market Size by Country (2018-2024)
9.4 Latin America Disease Control and Prevention Vaccine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Disease Control and Prevention Vaccine Market Size (2018-2029)
10.2 Middle East & Africa Disease Control and Prevention Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2018-2024)
10.4 Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Disease Control and Prevention Vaccine Introduction
11.1.4 GSK Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.1.5 GSK Recent Development
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Detail
11.2.2 Merck & Co., Inc Business Overview
11.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Introduction
11.2.4 Merck & Co., Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.2.5 Merck & Co., Inc Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Disease Control and Prevention Vaccine Introduction
11.3.4 Pfizer Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Disease Control and Prevention Vaccine Introduction
11.4.4 Sanofi Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.4.5 Sanofi Recent Development
11.5 AstraZeneca PLC
11.5.1 AstraZeneca PLC Company Detail
11.5.2 AstraZeneca PLC Business Overview
11.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Introduction
11.5.4 AstraZeneca PLC Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.5.5 AstraZeneca PLC Recent Development
11.6 Sinovac Biotech Ltd
11.6.1 Sinovac Biotech Ltd Company Detail
11.6.2 Sinovac Biotech Ltd Business Overview
11.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Introduction
11.6.4 Sinovac Biotech Ltd Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.6.5 Sinovac Biotech Ltd Recent Development
11.7 Astellas Pharma Inc
11.7.1 Astellas Pharma Inc Company Detail
11.7.2 Astellas Pharma Inc Business Overview
11.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Introduction
11.7.4 Astellas Pharma Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.7.5 Astellas Pharma Inc Recent Development
11.8 Serum Institute of India Pvt. Ltd
11.8.1 Serum Institute of India Pvt. Ltd Company Detail
11.8.2 Serum Institute of India Pvt. Ltd Business Overview
11.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Introduction
11.8.4 Serum Institute of India Pvt. Ltd Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.8.5 Serum Institute of India Pvt. Ltd Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Detail
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Introduction
11.9.4 Daiichi Sankyo Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.9.5 Daiichi Sankyo Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Detail
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Disease Control and Prevention Vaccine Introduction
11.10.4 Abbott Laboratories Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.10.5 Abbott Laboratories Recent Development
11.11 Bharat Biotech International
11.11.1 Bharat Biotech International Company Detail
11.11.2 Bharat Biotech International Business Overview
11.11.3 Bharat Biotech International Disease Control and Prevention Vaccine Introduction
11.11.4 Bharat Biotech International Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.11.5 Bharat Biotech International Recent Development
11.12 Bavarian Nordic A/S
11.12.1 Bavarian Nordic A/S Company Detail
11.12.2 Bavarian Nordic A/S Business Overview
11.12.3 Bavarian Nordic A/S Disease Control and Prevention Vaccine Introduction
11.12.4 Bavarian Nordic A/S Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.12.5 Bavarian Nordic A/S Recent Development
11.13 CSL Limited
11.13.1 CSL Limited Company Detail
11.13.2 CSL Limited Business Overview
11.13.3 CSL Limited Disease Control and Prevention Vaccine Introduction
11.13.4 CSL Limited Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.13.5 CSL Limited Recent Development
11.14 Emergent BioSolutions Inc
11.14.1 Emergent BioSolutions Inc Company Detail
11.14.2 Emergent BioSolutions Inc Business Overview
11.14.3 Emergent BioSolutions Inc Disease Control and Prevention Vaccine Introduction
11.14.4 Emergent BioSolutions Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.14.5 Emergent BioSolutions Inc Recent Development
11.15 Inovio Pharmaceuticals Inc
11.15.1 Inovio Pharmaceuticals Inc Company Detail
11.15.2 Inovio Pharmaceuticals Inc Business Overview
11.15.3 Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Introduction
11.15.4 Inovio Pharmaceuticals Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.15.5 Inovio Pharmaceuticals Inc Recent Development
11.16 Johnson & Johnson
11.16.1 Johnson & Johnson Company Detail
11.16.2 Johnson & Johnson Business Overview
11.16.3 Johnson & Johnson Disease Control and Prevention Vaccine Introduction
11.16.4 Johnson & Johnson Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.16.5 Johnson & Johnson Recent Development
11.17 Mitsubishi Tanabe Pharma Corporation
11.17.1 Mitsubishi Tanabe Pharma Corporation Company Detail
11.17.2 Mitsubishi Tanabe Pharma Corporation Business Overview
11.17.3 Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Introduction
11.17.4 Mitsubishi Tanabe Pharma Corporation Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.17.5 Mitsubishi Tanabe Pharma Corporation Recent Development
11.18 Novavax Inc
11.18.1 Novavax Inc Company Detail
11.18.2 Novavax Inc Business Overview
11.18.3 Novavax Inc Disease Control and Prevention Vaccine Introduction
11.18.4 Novavax Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.18.5 Novavax Inc Recent Development
11.19 Panacea Biotec Ltd
11.19.1 Panacea Biotec Ltd Company Detail
11.19.2 Panacea Biotec Ltd Business Overview
11.19.3 Panacea Biotec Ltd Disease Control and Prevention Vaccine Introduction
11.19.4 Panacea Biotec Ltd Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.19.5 Panacea Biotec Ltd Recent Development
11.20 Takeda Pharmaceutical Company Limited
11.20.1 Takeda Pharmaceutical Company Limited Company Detail
11.20.2 Takeda Pharmaceutical Company Limited Business Overview
11.20.3 Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Introduction
11.20.4 Takeda Pharmaceutical Company Limited Revenue in Disease Control and Prevention Vaccine Business (2018-2024)
11.20.5 Takeda Pharmaceutical Company Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Live-Attenuated
Table 3. Key Players of Inactivated
Table 4. Key Players of Recombinant Sub Unit and Toxoid
Table 5. Global Disease Control and Prevention Vaccine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Disease Control and Prevention Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Disease Control and Prevention Vaccine Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Disease Control and Prevention Vaccine Market Share by Region (2018-2024)
Table 9. Global Disease Control and Prevention Vaccine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Disease Control and Prevention Vaccine Market Share by Region (2024-2029)
Table 11. Disease Control and Prevention Vaccine Market Trends
Table 12. Disease Control and Prevention Vaccine Market Drivers
Table 13. Disease Control and Prevention Vaccine Market Challenges
Table 14. Disease Control and Prevention Vaccine Market Restraints
Table 15. Global Disease Control and Prevention Vaccine Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Disease Control and Prevention Vaccine Market Share by Players (2018-2024)
Table 17. Global Top Disease Control and Prevention Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2022)
Table 18. Ranking of Global Top Disease Control and Prevention Vaccine Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Disease Control and Prevention Vaccine Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Disease Control and Prevention Vaccine Product Solution and Service
Table 22. Date of Enter into Disease Control and Prevention Vaccine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Disease Control and Prevention Vaccine Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2024)
Table 26. Global Disease Control and Prevention Vaccine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2024-2029)
Table 28. Global Disease Control and Prevention Vaccine Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2024)
Table 30. Global Disease Control and Prevention Vaccine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2024-2029)
Table 32. North America Disease Control and Prevention Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Disease Control and Prevention Vaccine Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Disease Control and Prevention Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Disease Control and Prevention Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Disease Control and Prevention Vaccine Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Disease Control and Prevention Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Disease Control and Prevention Vaccine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Disease Control and Prevention Vaccine Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Disease Control and Prevention Vaccine Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Disease Control and Prevention Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Disease Control and Prevention Vaccine Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Disease Control and Prevention Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Disease Control and Prevention Vaccine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2024-2029) & (US$ Million)
Table 47. GSK Company Detail
Table 48. GSK Business Overview
Table 49. GSK Disease Control and Prevention Vaccine Product
Table 50. GSK Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 51. GSK Recent Development
Table 52. Merck & Co., Inc Company Detail
Table 53. Merck & Co., Inc Business Overview
Table 54. Merck & Co., Inc Disease Control and Prevention Vaccine Product
Table 55. Merck & Co., Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 56. Merck & Co., Inc Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Disease Control and Prevention Vaccine Product
Table 60. Pfizer Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Sanofi Company Detail
Table 63. Sanofi Business Overview
Table 64. Sanofi Disease Control and Prevention Vaccine Product
Table 65. Sanofi Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. AstraZeneca PLC Company Detail
Table 68. AstraZeneca PLC Business Overview
Table 69. AstraZeneca PLC Disease Control and Prevention Vaccine Product
Table 70. AstraZeneca PLC Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 71. AstraZeneca PLC Recent Development
Table 72. Sinovac Biotech Ltd Company Detail
Table 73. Sinovac Biotech Ltd Business Overview
Table 74. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product
Table 75. Sinovac Biotech Ltd Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 76. Sinovac Biotech Ltd Recent Development
Table 77. Astellas Pharma Inc Company Detail
Table 78. Astellas Pharma Inc Business Overview
Table 79. Astellas Pharma Inc Disease Control and Prevention Vaccine Product
Table 80. Astellas Pharma Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 81. Astellas Pharma Inc Recent Development
Table 82. Serum Institute of India Pvt. Ltd Company Detail
Table 83. Serum Institute of India Pvt. Ltd Business Overview
Table 84. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product
Table 85. Serum Institute of India Pvt. Ltd Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 86. Serum Institute of India Pvt. Ltd Recent Development
Table 87. Daiichi Sankyo Company Detail
Table 88. Daiichi Sankyo Business Overview
Table 89. Daiichi Sankyo Disease Control and Prevention Vaccine Product
Table 90. Daiichi Sankyo Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 91. Daiichi Sankyo Recent Development
Table 92. Abbott Laboratories Company Detail
Table 93. Abbott Laboratories Business Overview
Table 94. Abbott Laboratories Disease Control and Prevention Vaccine Product
Table 95. Abbott Laboratories Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 96. Abbott Laboratories Recent Development
Table 97. Bharat Biotech International Company Detail
Table 98. Bharat Biotech International Business Overview
Table 99. Bharat Biotech International Disease Control and Prevention Vaccine Product
Table 100. Bharat Biotech International Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 101. Bharat Biotech International Recent Development
Table 102. Bavarian Nordic A/S Company Detail
Table 103. Bavarian Nordic A/S Business Overview
Table 104. Bavarian Nordic A/S Disease Control and Prevention Vaccine Product
Table 105. Bavarian Nordic A/S Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 106. Bavarian Nordic A/S Recent Development
Table 107. CSL Limited Company Detail
Table 108. CSL Limited Business Overview
Table 109. CSL Limited Disease Control and Prevention Vaccine Product
Table 110. CSL Limited Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 111. CSL Limited Recent Development
Table 112. Emergent BioSolutions Inc Company Detail
Table 113. Emergent BioSolutions Inc Business Overview
Table 114. Emergent BioSolutions Inc Disease Control and Prevention Vaccine Product
Table 115. Emergent BioSolutions Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 116. Emergent BioSolutions Inc Recent Development
Table 117. Inovio Pharmaceuticals Inc Company Detail
Table 118. Inovio Pharmaceuticals Inc Business Overview
Table 119. Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Product
Table 120. Inovio Pharmaceuticals Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 121. Inovio Pharmaceuticals Inc Recent Development
Table 122. Johnson & Johnson Company Detail
Table 123. Johnson & Johnson Business Overview
Table 124. Johnson & Johnson Disease Control and Prevention Vaccine Product
Table 125. Johnson & Johnson Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 126. Johnson & Johnson Recent Development
Table 127. Mitsubishi Tanabe Pharma Corporation Company Detail
Table 128. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 129. Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Product
Table 130. Mitsubishi Tanabe Pharma Corporation Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 131. Mitsubishi Tanabe Pharma Corporation Recent Development
Table 132. Novavax Inc Company Detail
Table 133. Novavax Inc Business Overview
Table 134. Novavax Inc Disease Control and Prevention Vaccine Product
Table 135. Novavax Inc Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 136. Novavax Inc Recent Development
Table 137. Panacea Biotec Ltd Company Detail
Table 138. Panacea Biotec Ltd Business Overview
Table 139. Panacea Biotec Ltd Disease Control and Prevention Vaccine Product
Table 140. Panacea Biotec Ltd Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 141. Panacea Biotec Ltd Recent Development
Table 142. Takeda Pharmaceutical Company Limited Company Detail
Table 143. Takeda Pharmaceutical Company Limited Business Overview
Table 144. Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Product
Table 145. Takeda Pharmaceutical Company Limited Revenue in Disease Control and Prevention Vaccine Business (2018-2024) & (US$ Million)
Table 146. Takeda Pharmaceutical Company Limited Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Disease Control and Prevention Vaccine Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Disease Control and Prevention Vaccine Market Share by Type: 2022 VS 2029
Figure 3. Live-Attenuated Features
Figure 4. Inactivated Features
Figure 5. Recombinant Sub Unit and Toxoid Features
Figure 6. Global Disease Control and Prevention Vaccine Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 7. Global Disease Control and Prevention Vaccine Market Share by Application: 2022 VS 2029
Figure 8. Pediatric Vaccine Case Studies
Figure 9. Adult Vaccine Case Studies
Figure 10. Disease Control and Prevention Vaccine Report Years Considered
Figure 11. Global Disease Control and Prevention Vaccine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Disease Control and Prevention Vaccine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Disease Control and Prevention Vaccine Market Share by Region: 2022 VS 2029
Figure 14. Global Disease Control and Prevention Vaccine Market Share by Players in 2022
Figure 15. Global Top Disease Control and Prevention Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Disease Control and Prevention Vaccine Revenue in 2022
Figure 17. North America Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Disease Control and Prevention Vaccine Market Share by Country (2018-2029)
Figure 19. United States Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Disease Control and Prevention Vaccine Market Share by Country (2018-2029)
Figure 23. Germany Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Disease Control and Prevention Vaccine Market Share by Region (2018-2029)
Figure 31. China Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Disease Control and Prevention Vaccine Market Share by Country (2018-2029)
Figure 39. Mexico Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Disease Control and Prevention Vaccine Market Share by Country (2018-2029)
Figure 43. Turkey Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Disease Control and Prevention Vaccine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. GSK Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 46. Merck & Co., Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 47. Pfizer Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 48. Sanofi Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 49. AstraZeneca PLC Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 50. Sinovac Biotech Ltd Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 51. Astellas Pharma Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 52. Serum Institute of India Pvt. Ltd Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 53. Daiichi Sankyo Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 54. Abbott Laboratories Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 55. Bharat Biotech International Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 56. Bavarian Nordic A/S Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 57. CSL Limited Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 58. Emergent BioSolutions Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 59. Inovio Pharmaceuticals Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 60. Johnson & Johnson Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 61. Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 62. Novavax Inc Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 63. Panacea Biotec Ltd Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 64. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Disease Control and Prevention Vaccine Business (2018-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed